Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device 2024-04-02 21:00
China Medical University Hospital Develops "AISIA" to Diagnose Acute Ischemic Stroke in 90 Seconds to Assist Doctors in Making Medical Decisions 2024-04-02 20:30
Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction 2024-04-02 20:30
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH 2024-04-02 20:00
Gushengtang Releases 2023 Annual Results: Sustained Growth with Robust Profit Increase 2024-04-02 16:49
23WELL, THE health supplement brand on the watch 2024-04-02 09:07
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE 2024-03-30 11:00
Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle 2024-03-29 21:37
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Jacobio Pharma Announces 2023 Annual Results 2024-03-29 08:50
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2023 2024-03-28 20:30
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
1 33 34 35 36 37 431